Cargando…

Pathologic response with neoadjuvant chemotherapy and stereotactic body radiotherapy for borderline resectable and locally-advanced pancreatic cancer

BACKGROUND: Neoadjuvant stereotactic body radiotherapy (SBRT) has potential applicability in the management of borderline resectable and locally-advanced pancreatic adenocarcinoma. In this series, we report the pathologic outcomes in the subset of patients who underwent surgery after neoadjuvant SBR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rajagopalan, Malolan S, Heron, Dwight E, Wegner, Rodney E, Zeh, Herbert J, Bahary, Nathan, Krasinskas, Alyssa M, Lembersky, Barry, Brand, Randall, Moser, A James, Quinn, Annette E, Burton, Steven A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228466/ https://www.ncbi.nlm.nih.gov/pubmed/24175982 http://dx.doi.org/10.1186/1748-717X-8-254

Ejemplares similares

Stereotactic Body Radiation Therapy for Locally Progressive and Recurrent Pancreatic Cancer after Prior Radiation
por: Sutera, Philip, et al.
Publicado: (2018)

Stereotactic body radiotherapy in the treatment of Pancreatic Adenocarcinoma in elderly patients
por: Kim, Carolyn H, et al.
Publicado: (2013)

One- vs. Three-Fraction Pancreatic Stereotactic Body Radiation Therapy for Pancreatic Carcinoma: Single Institution Retrospective Review
por: Sutera, Philip Anthony, et al.
Publicado: (2017)

Prescription dose and fractionation predict improved survival after stereotactic radiotherapy for brainstem metastases
por: Leeman, Jonathan E, et al.
Publicado: (2012)

Patterns of Failure After Adjuvant Stereotactic Body Radiation Therapy for Pancreatic Cancer With Close or Positive Margins
por: Patel, Ankur K., et al.
Publicado: (2020)

Initial Results of a Prospective Study of Adjuvant Pancreatic Stereotactic Body Radiation Therapy for Close or Positive Margins
por: Bernard, Mark E., et al.
Publicado: (2018)

An Unexpected Etiology of Pancreatic Panniculitis: A Case Report
por: Evans, Anna C., et al.
Publicado: (2017)

Editorial: Clinical Application of Stereotactic Body Radiotherapy (SBRT): Cranium to Prostate
por: Vargo, John A., et al.
Publicado: (2015)

Pretreatment SUV(max) predicts progression-free survival in early-stage non-small cell lung cancer treated with stereotactic body radiation therapy
por: Horne, Zachary D, et al.
Publicado: (2014)

Stereotactic Ablative Radiation Therapy for Unresectable Colorectal Oligometastases
por: Sutera, Philip, et al.
Publicado: (2018)

Stereotactic Body Radiation Therapy for Pulmonary Oligometastases Arising from Non-lung Primaries in Patients Without Extrapulmonary Disease
por: Dohopolski, Michael J, et al.
Publicado: (2018)

SMAD4 loss is associated with response to neoadjuvant chemotherapy plus hydroxychloroquine in patients with pancreatic adenocarcinoma
por: Fei, Naomi, et al.
Publicado: (2021)

Prognostic Factors for Elderly Patients Treated With Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma
por: Sutera, Philip A., et al.
Publicado: (2018)

Tumor Bed Radiosurgery Following Resection and Prior Stereotactic Radiosurgery for Locally Persistent Brain Metastasis
por: Holt, Douglas Emerson, et al.
Publicado: (2015)

Salvage Stereotactic Body Radiotherapy for Locally Recurrent Non-Small Cell Lung Cancer after Sublobar Resection and I(125) Vicryl Mesh Brachytherapy
por: Gill, Beant S., et al.
Publicado: (2015)

Stereotactic Body Radiotherapy as Primary Treatment for Elderly Patients with Medically Inoperable Head and Neck Cancer
por: Vargo, John A., et al.
Publicado: (2014)

Overweight or Obese Individuals at Eighteen Years of Age Develop Pancreatic Adenocarcinoma at a Significantly Earlier Age
por: Chao, David T., et al.
Publicado: (2018)

EGFR Signaling in Colorectal Carcinoma
por: Krasinskas, Alyssa M.
Publicado: (2011)

A retrospective, deformable registration analysis of the impact of PET-CT planning on patterns of failure in stereotactic body radiation therapy for recurrent head and neck cancer
por: Wang, Kyle, et al.
Publicado: (2012)

Exceptional Eight-year Response to Stereotactic Radiosurgery Monotherapy for Multiple Brain Metastases
por: Kalash, Ronny, et al.
Publicado: (2017)

Stereotactic ablative body radiotherapy versus conventionally fractionated radiotherapy for early stage large cell neuroendocrine carcinoma of the lung
por: Wegner, Rodney E, et al.
Publicado: (2020)

Stereotactic Ablative Radiosurgery for Locally Advanced or Recurrent Skull Base Malignancies with Prior External Beam Radiation Therapy
por: Xu, Karen M., et al.
Publicado: (2015)

Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Lung Nodules: A Single Institution Series
por: Wegner, Rodney E., et al.
Publicado: (2019)

Treatment Plan Technique and Quality for Single-Isocenter Stereotactic Ablative Radiotherapy of Multiple Lung Lesions with Volumetric-Modulated Arc Therapy or Intensity-Modulated Radiosurgery
por: Quan, Kimmen, et al.
Publicado: (2015)

Stereotactic body radiotherapy for central lung tumors: Finding the balance between safety and efficacy in the “no fly” zone
por: Ahmed, Nissar, et al.
Publicado: (2018)

Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer
por: Alva-Ruiz, Roberto, et al.
Publicado: (2021)

Utilization of Stereotactic Ablative Body Radiation Therapy for Intact Renal Cell Carcinoma: Trends in Treatment and Predictors of Outcome
por: Wegner, Rodney E., et al.
Publicado: (2019)

Neoadjuvant Treatment in Patients With Resectable and Borderline Resectable Pancreatic Cancer
por: Janssen, Quisette P., et al.
Publicado: (2020)

Editorial: Neoadjuvant treatment for resectable and borderline resectable pancreatic cancer
por: Massani, Marco, et al.
Publicado: (2023)

Lung stereotactic body radiotherapy after past ablative therapy: a single institution case series
por: Wegner, Rodney E, et al.
Publicado: (2018)

Stereotactic body radiation therapy in early-stage NSCLC: historical review, contemporary evidence and future implications
por: Abel, Stephen, et al.
Publicado: (2019)

Stereotactic body radiation therapy versus fractionated radiation therapy for early-stage bronchopulmonary carcinoid
por: Wegner, Rodney E, et al.
Publicado: (2019)

A phase II trial proposal of total neoadjuvant treatment with primary chemotherapy, stereotactic body radiation therapy, and intraoperative radiation therapy in borderline resectable pancreatic adenocarcinoma
por: Paiella, Salvatore, et al.
Publicado: (2021)

Impact of somatic mutations on clinical and pathologic outcomes in borderline resectable and locally advanced pancreatic cancer treated with neoadjuvant chemotherapy and stereotactic body radiotherapy followed by surgical resection
por: Reddy, Abhinav V., et al.
Publicado: (2021)

Surgical resection versus stereotactic body radiation therapy in early stage bronchopulmonary large cell neuroendocrine carcinoma
por: Lo, Herman, et al.
Publicado: (2019)

Long-Term Patient-Reported Quality of Life After Stereotactic Body Radiation Therapy for Recurrent, Previously-Irradiated Head and Neck Cancer
por: Thomas, Joel, et al.
Publicado: (2020)

Predictors of Treatment Interruption During Frameless Gamma Knife Icon Stereotactic Radiosurgery
por: Wegner, Rodney E., et al.
Publicado: (2020)

Neoadjuvant chemoradiation therapy for borderline pancreatic adenocarcinoma: report of two cases
por: Galindo, José, et al.
Publicado: (2013)

Neoadjuvant Treatment for Resectable and Borderline Resectable Pancreatic Cancer: Chemotherapy or Chemoradiotherapy?
por: Versteijne, Eva, et al.
Publicado: (2022)

Borderline resectable pancreatic cancer and vascular resections in the era of neoadjuvant therapy
por: Mikulic, Danko, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5tf357v9k5kvnrh35p465j9u0p